header logo en

Trial Results

The following table lists the results of some of the many clinical trials available worldwide for kidney cancer patients. For more information about some of the ongoing trials, click here.

Note: The following lay summaries are provided for Patient Organizations to better understand the results of recent clinical trials. While these have been medically reviewed, please consult the cited Journals for full data.

Date published  Trial name Results  Agents  Phase  Status  Sponsor
 Sept.
 2017
Checkmate 214 (for trial info please click here: Checkmate 214)
To view trial infographic click here: Infographic study results Checkmate 214
 
For a summary of the study results, read here: Study results summary
Nivolumab+ipilimumab
versus sunitinib
 III Closed, results published Bristol-Myers Squibb
 Feb.
 2017
IMmotion150 For results please click here atezolizumab, bevacizumab, sunitinib II still ongoing but not recruiting Hoffmann-La Roche
 Sept.
 2016
 METEOR
To view trial infographic click here: Infographic study results METEOR
 
For a summary of the study results, read here: Study results summary
cabozantinib + everolimus  III still ongoing but not recruiting  Exelixis
 Sept.
 2015
Pembrolizumab + pazopanib (for trial info please click here: Pembrolizumab + pazopanib) For results please click here pembrolizumab + pazopanib  I still ongoing, preliminary results published Novartis
 Sept.
 2015
Checkmate 025 (for trial info please click here: Checkmate 025)
To view trial infographic click here: Infographic study results Checkmate 025
 
For a summary of the study results, read here: Study results summary
nivolumab versus everolimus
 III Stopped, results published Bristol-Myers Squibb